Stockreport

IMDX Reports Q3 2025 Results and Progress Toward 2026 Commercial Launch [Yahoo! Finance]

Insight Molecular Diagnostics Inc.  (IMDX) 
PDF On track for commitment to have 20 transplant centers globally engaged with GraftAssure technology by end of 2025 GraftAssure assay's head-to-head data continue to be [Read more]